Comparison of the efficacy and safety of on-demand maximum dosing of sildenafil and Low-intensity shockwave therapy for erectile dysfunction

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021685

Enrollment

Unknown

Registered

2019-03-05

Start date

2019-03-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfuntion

Interventions

Trial Group:LI-ESWT

Controlled Group:Sildenafil

Eligibility

Sex/Gender

Male

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged = 18 years, in a monogamous relationship with a female partner, who reported = three-month history of erectile dysfunction and complaining of insufficient erection to finish sexual intercourse are included.

Exclusion criteria

Exclusion criteria: Men with abnormal anatomical abnormality, an unstable medical (including clinically significant hepatobiliary or renal disease, and unstable cardiovascular disease) or psychiatric condition, with a previous history of a neurological pathology and after radical pelvic surgery, irradiations, or hormonal therapy as well as ED caused by other sexual or endocrine disorders such as premature ejaculation or hypogonadism were excluded.

Design outcomes

Primary

Measure	Time frame
IIEF-EF;EHS;SEAR;EDITS;	—

Countries

China

Contacts

Public ContactYan Su

Department of Urology, ?????? ?????? ?????? Peking Union Medical College Hospital; Peking Union Medical College Hospital (PUMCH)

dryansu@126.com+86 13801326306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026